After 10 straight wins, Lions face Packers with much to accomplish
This artist’s rendering shows the proposed design for Pierpont Community & Technical College’s new aviation maintenance training facility. BRIDGEPORT, W.Va. (WV News) — During the special session held in August, 2023, the West Virginia Legislature passed a bill allocating $25 million that was said to be to construct a new facility to house Pierpont Community & Technical College's Aviation Maintenance Technology program. More than a year later, progress on the facility has yet to begin. But local lawmakers have said the project is still viable and in the works. Gov. Jim Justice signed Senate Bill 1029 into law during a ceremony in Bridgeport on Aug. 17, 2023. West Virginia Senate President Craig Blair, left, and Gov. Jim Justice hold up a signed copy of Senate Bill 1029 during a ceremony in Bridgeport in Aug. 2023. “More employment, more goodness, more opportunity — that’s exactly what is happening right in front of us,” he said. SB 1029 was a $52.7 million appropriations bill containing funding for 14 items. Some of the items are specifically spelled out in the text of the bill, such as $241,570 for the National Youth Science Camp and $500,000 for the Marshall University Research Corporation. The $25 million intended for Pierpont's facility is listed as "Directed Transfer - surplus" that "shall be transferred to the Economic Development Fund." The word "Pierpont" does not appear in the text of SB 1029. However, local lawmakers say that the bill's intent was clear and was Gov. Justice's intentions. Pierpont’s aviation program has long been an important source of workforce development for the aerospace businesses on the campus of North Central West Virginia Airport like Boeing subsidiary Auroa Flight Sciences, Lockheed Martin and MHIRJ. Students can earn a a degree in Aviation Maintenance Technology, allowing them to pursue well-paid aerospace industry careers such as airframe maintenance mechanic, avionics technician and aviation maintenance director. The program is currently operating at capacity and has outgrown its current location. The new facility would allow the program to expand from 130 to 200 students per class, according to officials. State lawmakers are "working diligently to make sure this happens," said Sen. Ben Queen, R-Harrsion. "Obviously, we want this to happen under the Justice administration, but the legislature appropriated the money, so I don't have a real big worry that if the administrations changes, that the Morrisey administration won't follow through with this bill," he said. Queen This project would be one of the first where the state EDA constructs and owns a new building, as opposed to taking over an existing facility, Queen said. Progress toward getting the project started is ongoing, Queen said. "We have been in discussions just the last two weeks and are doing everything we can to make this happen and to have an announcement by the end of the year," he said. Del. Clay Riley, R-Harrison, advocates for passage of Senate Bill 1029, which included funds for Pierpont Community & Technical College, during the Aug. 2023 special session of the West Virginia Legislature. Del. Clay Riley, R-Harrsion, who advocated for the funding on the floor of the State House of Delegates, said the project is in the "design phase." "I hope it will going to bid soon. I don't have an update that it will, but it would be my anticipation that it would," he said. "Obviously, that's a very critical component to North Central West Virginia (Airport) and the employment there. I would hope that whatever the stumbling blocks may be, that they get worked out pretty quickly." C.J. Harvey, director of communications for Justice's office, said he didn't have information to provide about the project's current status, but said the governor "remains very enthusiastic for the aerospace industry's future, particularly in North Central West Virginia, where recent investments are positioning the region as a leader." "Under Gov. Justice's leadership, West Virginia continues to diversify its economy and show the world the monumental changes happening in the Mountain State," Harvey said in an email to WV News. As originally described, the new 70,000-square-foot Pierpont facility will occupy around 6 acres in the new West Virginia AeroTech Park, where the airport's recently-completed terminal building is located. The new Pierpoint facility will occupy around 6 acres in the new West Virginia AeroTech Park, which is adjacent to W.Va. 279. The proposed design features two high bay hangars, aviation-related specialty labs, including shops for turbine and reciprocating engine overhauls, flight controls and hydraulics, lecture classrooms and a learning resource and testing center.After 10 straight wins, Lions face Packers with much to accomplish
The Earth's Corr: Traffic gridlock here to stay unless funding and mindsets shift( ) stock surged on Tuesday after the cybersecurity firm reported third-quarter earnings and revenue that topped consensus estimates. Revenue guidance also came in above views. Reported after the market close, Okta earnings were 67 cents per share on an adjusted basis for the quarter ending Oct. 31, up 52% from a year earlier. San Francisco-based Okta said revenue climbed 14% to $665 million. Analysts had expected Okta earnings of 58 cents on revenue of $650 million. "Results were highlighted by subscription revenue growth of 14% to $651 million vs. consensus at $635 million," RBC Capital analyst Matthew Hedberg said in a report. For the current January quarter, Okta predicted revenue growth of 10.5% to $668 million, topping estimates of $651 million. Okta Stock Jumps On Q3 Results On the , Okta stock surged more than 15% to 94.58 in extended trading. OKTA had retreated 12% in 2024 prior to the earnings report. The company's security software monitors and manages privileged accounts. Hackers often target employees or management with administrative access to company computer systems. Heading into the earnings report, Okta owned a Relative Strength Rating of 24 out of a best-possible 99, according to . Growing competition from ( ) is one issue for Okta stock.
SAN DIEGO--(BUSINESS WIRE)--Dec 3, 2024-- Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, today announced that it has commenced an underwritten public offering of $300.0 million of shares of its common stock or, in lieu of common stock issued to certain investors that so choose, pre-funded warrants to purchase shares of its common stock. In addition, Janux expects to grant the underwriters a 30-day option to purchase up to an additional $45.0 million of shares of its common stock at the public offering price, less the underwriting discounts and commissions. All of the securities to be sold in the offering are to be sold by Janux. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering. BofA Securities, TD Cowen, Stifel, Cantor and William Blair are acting as joint book-running managers for the offering. Wedbush PacGrow, LifeSci Capital, BTIG and Jones are acting as co-managers for the offering. The Company intends to use the net proceeds from the offering to advance clinical development of its internal product pipeline and for general corporate purposes. The securities are being offered by the company pursuant to a Registration Statement on Form S-3 filed with the Securities and Exchange Commission (SEC) that became automatically effective upon filing. A preliminary prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website, located at www.sec.gov . Copies of the preliminary prospectus supplement and the accompanying prospectus relating to this offering may be obtained, when available, from: BofA Securities, NC1-022-02-25, 201 North Tryon Street, Charlotte, North Carolina 28255-0001, Attention: Prospectus Department, or by email at dg.prospectus_requests@bofa.com ; TD Securities (USA) LLC, 1 Vanderbilt Avenue, New York, New York 10017, by telephone at (855) 495-9846 or by email at TD.ECM_Prospectus@tdsecurities.com ; Stifel, Nicolaus & Company, Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, California 94104, by telephone at (415) 364-2720, or by email at syndprospectus@stifel.com ; Cantor Fitzgerald & Co., Attention: Capital Markets, 110 East 59th Street, 6th Floor, New York, New York 10022, or by email at prospectus@cantor.com ; or William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, Illinois 60606, by telephone at (800) 621-0687 or by email at prospectus@williamblair.com . This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Janux Therapeutics, Inc. Janux is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Janux’s proprietary technology enabled the development of two distinct bispecific platforms: TRACTr and TRACIr. The goal of both platforms is to provide cancer patients with safe and effective therapeutics that direct and guide their immune system to eradicate tumors while minimizing safety concerns. Janux is currently developing a broad pipeline of TRACTr and TRACIr therapeutics directed at several targets to treat solid tumors. Janux has two TRACTr therapeutic candidates in clinical trials, the first targeting PSMA is in development for prostate cancer, and the second targeting EGFR is being developed for colorectal carcinoma, squamous cell carcinoma of the head and neck, non-small cell lung cancer, renal cell carcinoma, small cell lung cancer, pancreatic ductal adenocarcinoma and triple-negative breast cancer. Forward-Looking Statements Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding, among other things, the timing, size, terms and completion of the proposed public offering, the anticipated use of proceeds therefrom and the grant of the option to purchase additional shares. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon Janux’s current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks and uncertainties associated with market conditions, the satisfaction of customary closing conditions related to the proposed public offering, and the other risks described in Janux’s filings with the SEC. All forward-looking statements contained in this press release speak only as of the date on which they were made. Janux undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law. View source version on businesswire.com : https://www.businesswire.com/news/home/20241203439676/en/ CONTACT: Investors:Andy Meyer Janux Therapeutics ameyer@januxrx.com (202) 215-2579Media:Jessica Yingling, Ph.D. Little Dog Communications Inc. jessica@litldog.com (858) 344-8091 KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: SCIENCE OTHER SCIENCE BIOTECHNOLOGY RESEARCH PHARMACEUTICAL ONCOLOGY HEALTH OTHER HEALTH SOURCE: Janux Therapeutics Copyright Business Wire 2024. PUB: 12/03/2024 04:01 PM/DISC: 12/03/2024 04:02 PM http://www.businesswire.com/news/home/20241203439676/enMacron welcomes Trump in Paris with presidential pomp
Manchester City’s crisis deepened as they surrendered a three-goal lead late in the game to draw 3-3 against Feyenoord in the Champions League. Pep Guardiola’s side at least avoided the indignity of a sixth successive defeat in all competitions but alarm bells continue to ring at the Etihad Stadium after a dramatic late capitulation. A double from Erling Haaland – the first from the penalty spot – and a deflected effort from Ilkay Gundogan, all in the space of nine minutes either side of the break, looked to have ensured a return to winning ways. Yet Guardiola was left with his head in hands as Feyenoord roared back in the last 15 minutes with goals from Anis Hadj Moussa, Sergio Gimenez and David Hancko, two of them after Josko Gvardiol errors. City almost snatched a late winner when Jack Grealish hit the woodwork but there was no masking another dispiriting result. It was hardly the preparation City wanted for Sunday’s crunch trip to Liverpool, and the Feyenoord fans took great delight in rubbing that fact in. They sung the club anthem they share with Liverpool, You’ll Never Walk Alone, and chanted the name of their former manager Arne Slot, the current Reds boss. Guardiola arrived at the ground with a cut on the bridge of his nose and, once again, his side have been struck a nasty blow. Despite not being at their best, they had dominated early on against what seemed limited Dutch opposition. They threatened when a Gundogan shot was deflected wide and Haaland then went close to opening the scoring when he turned a header onto the post. Feyenoord goalkeeper Timon Wellenreuther gifted City another chance when he passed straight to Bernardo Silva but Grealish’s fierce volley struck team-mate Phil Foden. Foden forced a save from Wellenreuther but City had a moment of alarm when Igor Paixao got behind the defence only to shoot tamely at Ederson. Nathan Ake missed the target with a header but some luck finally went City’s way just before the break when Quinten Timber, brother of Arsenal’s Jurrien, was harshly adjudged to have fouled Haaland. The Norwegian rammed home the resulting spot-kick and City returned re-energised for the second period. They won a corner when a Matheus Nunes shot was turned behind and Gundogan fired the hosts’ second – albeit with aid of a deflection – with a firm volley from the edge of the box. City turned up the heat and claimed their third soon after as Gundogan released Nunes with a long ball and his low cross was turned into the net by a sliding Haaland. 44' ⚽️ Man City 1-0 Feyenoord50' ⚽️ Man City 2-0 Feyenoord53' ⚽️ Man City 3-0 Feyenoord75' ⚽️ Man City 3-1 Feyenoord82' ⚽️ Man City 3-2 Feyenoord89' ⚽️ Man City 3-3 Feyenoord 🤯🤯🤯 #UCL — UEFA Champions League (@ChampionsLeague) November 26, 2024 It seemed City were heading for a morale-lifting victory but a couple of Gvardiol errors changed the script. The Croatian, who had a torrid time in Saturday’s 4-0 thrashing by Tottenham, first horribly misplaced a backpass and allowed Moussa to nip in and round Ederson. Ordinarily that 75th-minute reply would have been a mere consolation and City would close out the game, but Gvardiol had another moment to forget eight minutes from time. Again he gave the ball away and Feyenoord pounced. The ball was lofted into the box and Jordan Lotomba fired a shot that glanced the post and deflected across goal, where Gimenez chested in. Ederson then blundered as he raced out of his area and was beaten by Paixao, who crossed for Hancko to head into an empty net. Amid some moments of unrest in the crowd, when objects were thrown, City tried to rally in stoppage time. Grealish had an effort deflected onto the bar but the hosts had to settle for a draw.
NoneHaryana chief minister (CM) Nayab Singh Saini on Saturday announced an ambitious target of creating 1,800 TB-free gram panchayats by March 2025. This follows the state’s success in declaring 579 gram panchayats TB-free in 2023. Sharing progress made under the state’s TB elimination initiatives at the launch of the nationwide 100-Day TB Elimination Campaign in Panchkula, Saini highlighted that the data of 79,652 patients from Haryana has been uploaded to the Ni-kshay portal. He added that 3.49 lakh TB patients have so far received financial assistance worth ₹ 117.46 crore under the Ni-kshay Poshan Yojana (NPY). Saini also emphasised Haryana’s adoption of advanced technologies to combat TB. The state has connected X-ray centres to the Indian Plasma Research Institute in Ahmedabad through AI, becoming the second state in the country to do so. Additionally, two cutting-edge microbial culture and DST labs have been established in Rohtak and Karnal, with a third lab under development in Ambala. “To reach vulnerable populations, 59 mobile health vans are conducting TB tests in villages, slums and among daily wage workers, brick kiln workers, and farmers,” Saini said. The state has also increased its designated microscopy centres (DMCs) for sample testing from 358 to 428, with plans to open 131 new DMCs. Handheld X-ray devices with AI capabilities are being deployed across districts for faster diagnostics. The CM assured that all TB diagnostic tests and treatments are being provided free of charge. Patients are also receiving free treatment under the Ayushman Bharat scheme in both government and private sectors. “So far, claims worth ₹ 29 crore for 17,500 TB patients have been settled under the scheme. For those not eligible for Ayushman, free treatment is still ensured,” Saini added. Highlighting efforts to treat drug-resistant TB cases, Saini noted the establishment of four nodal drug-resistant TB centres at PGIMS Rohtak and medical colleges in Karnal, Nuh, and Sonipat. Furthermore, district nodal drug-resistant TB centres have been set up in all 22 districts of Haryana. 65 hi-tech mobile vans deployed The Haryana government also launched 65 mobile vans (Ni-kshay vahan) equipped with advanced diagnostic tools in all districts of the state. The mobile vans will target high-risk areas, such as villages and urban settlements. These vehicles are equipped to perform chest X-rays and sputum tests on-site. Results will be available within 24 hours, and treatment for confirmed TB cases will commence immediately. As part of the campaign, the government has also launched the “Nikshay Mitra” initiative, where volunteers adopt TB patients and provide regular support, including follow-ups every 15 days. The campaign includes a detailed micro-planning strategy to maximise reach and effectiveness. Department officials, including ASHA workers and ANMs, will work in collaboration to identify and treat TB patients. The TB treatment is being provided free of cost under the government’s initiative. Patients will also receive ₹ 1,000 per month in their bank accounts to support nutritional needs during treatment. Energy tablets are being distributed as part of the program to ensure faster recovery.
China presses ahead with plans to build mega-dam near IndiaPep Guardiola’s side at least avoided the indignity of a sixth successive defeat in all competitions but alarm bells continue to ring at the Etihad Stadium after a dramatic late capitulation. A double from Erling Haaland – the first from the penalty spot – and a deflected effort from Ilkay Gundogan, all in the space of nine minutes either side of the break, looked to have ensured a return to winning ways. Yet Guardiola was left with his head in hands as Feyenoord roared back in the last 15 minutes with goals from Anis Hadj Moussa, Sergio Gimenez and David Hancko, two of them after Josko Gvardiol errors. City almost snatched a late winner when Jack Grealish hit the woodwork but there was no masking another dispiriting result. It was hardly the preparation City wanted for Sunday’s crunch trip to Liverpool, and the Feyenoord fans took great delight in rubbing that fact in. They sung the club anthem they share with Liverpool, You’ll Never Walk Alone, and chanted the name of their former manager Arne Slot, the current Reds boss. Guardiola arrived at the ground with a cut on the bridge of his nose and, once again, his side have been struck a nasty blow. Despite not being at their best, they had dominated early on against what seemed limited Dutch opposition. They threatened when a Gundogan shot was deflected wide and Haaland then went close to opening the scoring when he turned a header onto the post. Feyenoord goalkeeper Timon Wellenreuther gifted City another chance when he passed straight to Bernardo Silva but Grealish’s fierce volley struck team-mate Phil Foden. Foden forced a save from Wellenreuther but City had a moment of alarm when Igor Paixao got behind the defence only to shoot tamely at Ederson. Nathan Ake missed the target with a header but some luck finally went City’s way just before the break when Quinten Timber, brother of Arsenal’s Jurrien, was harshly adjudged to have fouled Haaland. The Norwegian rammed home the resulting spot-kick and City returned re-energised for the second period. They won a corner when a Matheus Nunes shot was turned behind and Gundogan fired the hosts’ second – albeit with aid of a deflection – with a firm volley from the edge of the box. City turned up the heat and claimed their third soon after as Gundogan released Nunes with a long ball and his low cross was turned into the net by a sliding Haaland. 44' ⚽️ Man City 1-0 Feyenoord50' ⚽️ Man City 2-0 Feyenoord53' ⚽️ Man City 3-0 Feyenoord75' ⚽️ Man City 3-1 Feyenoord82' ⚽️ Man City 3-2 Feyenoord89' ⚽️ Man City 3-3 Feyenoord 🤯🤯🤯 — UEFA Champions League (@ChampionsLeague) It seemed City were heading for a morale-lifting victory but a couple of Gvardiol errors changed the script. The Croatian, who had a torrid time in Saturday’s 4-0 thrashing by Tottenham, first horribly misplaced a backpass and allowed Moussa to nip in and round Ederson. Ordinarily that 75th-minute reply would have been a mere consolation and City would close out the game, but Gvardiol had another moment to forget eight minutes from time. Again he gave the ball away and Feyenoord pounced. The ball was lofted into the box and Jordan Lotomba fired a shot that glanced the post and deflected across goal, where Gimenez chested in. Ederson then blundered as he raced out of his area and was beaten by Paixao, who crossed for Hancko to head into an empty net. Amid some moments of unrest in the crowd, when objects were thrown, City tried to rally in stoppage time. Grealish had an effort deflected onto the bar but the hosts had to settle for a draw.Ravinia Brewing rebranding as Steep Ravine, closing Logan Square taproom
UnitedHealth projects 2025 operating cash flow below estimates
President Joe Biden ’s expansive pardon for his son, Hunter Biden, quashed any possibility of the first son facing new charges during the incoming Trump administration and limited his whole family’s exposure to prosecution related to his efforts to trade on his father’s influence. The president's pardon for his son stretched back to Jan. 1, 2014, and covered all other charges Hunter Biden could face, including violations of the Foreign Agents Registration Act . Hunter Biden had come under investigation by the Department of Justice and House Republicans for possible breaches of FARA that were related, in part, to his lucrative seat on the board of the Ukrainian energy company Burisma, a position he was given in 2014 while his father was vice president. Under FARA, U.S. citizens who work as “agents of a foreign principal” are required to disclose to the U.S. government any lobbying and public relations work they are doing on behalf of foreign entities. A FARA conviction carries a maximum penalty of up to five years in prison. Last year, House Republicans and the conservative group America First Legal brought to light emails between Hunter Biden (in his capacity as a Burisma board member), Obama administration officials, and a U.S. firm called Blue Star Strategies that suggested the first son was, in fact, engaging in lobbying during his time on Burisma's board. One indication that the president may have skirted FARA is the revelation last year that Blue Star Strategies, which the first son sought out to help Burisma in 2015, was forced to retroactively register its Burisma lobbying work under FARA in 2022 after coming under DOJ investigation. “Notably, the pardon covers the entire time that Hunter served on the board of Burisma, the Ukrainian natural gas company, and improperly lobbied the U.S. government on its behalf,” Reed Rubinstein, America First Legal senior vice president, said in a statement. Special counsel David Weiss brought two indictments against Hunter Biden last year but never charged him under FARA. In the first case, Hunter Biden was convicted by a jury of illegally possessing a gun while addicted to drugs. In the second case, he pleaded guilty to nine tax charges. Critics of the Biden family were far more interested in the tax case, which shed light on Hunter Biden's income from his business dealings abroad. He made more than $7 million from his foreign ventures in a four-year period while failing to pay his income taxes, the indictment revealed. The House Oversight Committee, which led Republicans' wide-ranging impeachment inquiry into the president, had shown in its own sprawling investigation of the Biden family that both Hunter Biden and his uncle James Biden raked in millions of dollars by invoking the president's name to their foreign partners in Ukraine, China, and elsewhere while offering scant services in return for the money. The Republicans alleged that the president helped his son and brother to profit by improperly flaunting his political influence in phone calls and meetings, an allegation all three Bidens have denied. A senior aide with the committee told the Washington Examiner that Hunter Biden, in particular, was only ever charged with a “fraction of the crimes he committed.” “Due to President Biden’s broad and sweeping pardon, Hunter Biden will escape accountability for numerous offenses,” the aide said. “This exemplifies corruption at its core.” The aide also credited two IRS whistleblowers, both of whom worked as criminal investigators on the DOJ’s investigation into Hunter Biden, with exposing “politicization and misconduct” at the department. Weiss willfully allowed the first son to avoid additional charges and prevented a deeper examination of the Biden family's foreign income, the whistleblowers alleged. Weiss has denied extending Hunter Biden any special treatment. The whistleblowers were the first to reveal last year that a FARA charge against Hunter Biden had been on the table but that prosecutors appeared uninterested in exploring the option and eventually allowed its five-year statute of limitations to expire. One of the whistleblowers' lawyers, Tristan Leavitt, who is president of the whistleblower advocacy group Empower Oversight, told the Washington Examiner that attaching conspiracy charges to the FARA charge could reset the statute of limitations and reopen a case against the Bidens. A Trump DOJ and FBI could have pursued such a prosecution, but now they cannot because of the pardon. Trump's nominee for FBI director, Kash Patel, has explicitly said Hunter Biden should have been prosecuted for FARA and possibly bribery had it not been for what Patel perceived was a "two-tier system of justice." Trump's intention to dramatically shake up his DOJ by putting figures such as Patel in charge could explain the breadth of the president's pardon, which was historically sweeping and prompted comparisons to the pardon former President Richard Nixon received in the Watergate era. The pardon covered all crimes Hunter Biden has or may have committed during an 11-year period. CLICK HERE TO READ MORE FROM THE WASHINGTON EXAMINER "This appears to be the broadest presidential pardon in American history, covering any potential criminal act Hunter Biden ever committed back to 2014, when the Bidens’ dealings in Ukraine netted Hunter a $1 million/year contract with Burisma," Leavitt said, adding that the pardon "raises major questions the American people need answered." White House press secretary Karine Jean-Pierre said Monday that the president plans to issue more pardons before he leaves office, but it remains unclear whether he will extend a pardon to his brother James Biden to erase any exposure he might have to FARA or other charges in a Trump administration.
UnitedHealth projects 2025 operating cash flow below estimates